A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8
Administration, Intranasal
Animals
CD8-Positive T-Lymphocytes
/ metabolism
Cancer Vaccines
/ administration & dosage
Cell Line
Disease Progression
Emulsions
Humans
Laminin
/ chemistry
Lymphocyte Activation
/ drug effects
Lymphoma
/ drug therapy
Mice
Nanoparticles
Ovalbumin
/ chemistry
Peptide Fragments
/ administration & dosage
Th1 Cells
/ metabolism
Epitope peptide
Nanovaccine
Nasal immunization
Tumor immunotherapy
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
31 Jul 2021
31 Jul 2021
Historique:
received:
26
03
2021
revised:
13
05
2021
accepted:
23
05
2021
pubmed:
31
5
2021
medline:
29
7
2021
entrez:
30
5
2021
Statut:
ppublish
Résumé
Epitope peptides are not suitable for nasal administration immunity due to their poor immunogenicity and low delivery efficiency. Here, we reported an intranasal self-assembled nanovaccine (I-OVA NE), which was loaded with the peptides IKVAV-OVA
Identifiants
pubmed: 34052270
pii: S0141-8130(21)01133-8
doi: 10.1016/j.ijbiomac.2021.05.158
pii:
doi:
Substances chimiques
Cancer Vaccines
0
Emulsions
0
Laminin
0
Peptide Fragments
0
isoleucyl-lysyl-valyl-alanyl-valine
131167-89-0
Ovalbumin
9006-59-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1891-1902Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.